Le Lézard
Classified in: Health
Subjects: PER, REL

Solidarity HealthShare CEO, Bradley L. Hahn, J.D. Appointed to Benedictine College's 'Transform Culture in America' Subcommittee


TEMPE, Ariz., April 16, 2019 /PRNewswire/ -- Solidarity HealthShare CEO, Bradley L. Hahn, J.D., has been appointed to Benedictine College's Transform Culture in America committee serving on the subcommittee for Science and Healthcare. 

In 2019 Obamacare Will Force More Americans to Choose Between Healthcare and Conscience, Abortions up 23%, Pro-Life Americans Now Have a Choice (PRNewsfoto/Solidarity HealthShare)

The Science and Healthcare subcommittee will focus on steps the college can take to fulfill its mission as a Catholic, liberal arts college educating doctors, scientists, and healthcare professionals for the 21st century. It will also work to dispel the myth that science and faith are inherently at odds and restore the undeniable truth of the dignity of the human person. These principles should be at the center of science and healthcare professions.

"Faith, morality, and ethics are just as important in the sciences and healthcare as in every other part of our lives. They cannot and should not be separated. It's the focus of what we do at Solidarity HealthShare. That's why we believe it's critical to train future doctors and scientists the essential role of faith, morality, and ethics in the sciences," said Solidarity HealthShare CEO, Bradley, L. Hahn, J.D.

Nine subcommittees will examine the impact the college can have on culture including: Commerce and Finance with banking and business leaders; Technology with engineers and entrepreneurs; and Science and Healthcare, gathering leading doctors and scientists.

Other nationally known experts include: EWTN's Raymond Arroyo and U.S. Rep. Jeff Fortenberry.

"We have spent ten years with the goal of building one of the great Catholic colleges in America," said President Stephen D. Minnis. "Now we are asking the question: Why? What can a great Catholic college do? How can we transform culture in America?"

Solidarity HealthShare is a healthcare sharing ministry that offers its members an affordable and ethical way to pay for healthcare. Based on the social and moral doctrine of the Catholic Church, we protect our members' well-formed consciences by sharing in the costs of life-affirming healthcare, and by refusing to participate in unethical medical practices. Our mission is to restore and rebuild an authentic Catholic healthcare culture that promotes the sanctity of all human life, while facilitating the sharing of our members' medical expenses.

 

SOURCE Solidarity HealthShare


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: